Seminars in Hematology aims to present subjects of current importance in clinical hematology, including related areas of oncology, hematopathology, and blood banking. The journal's unique issue structure allows for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering a variety of articles that present dynamic and front-line material immediately influencing the field. Seminars in Hematology is devoted to making the important and current work accessible, comprehensible, and valuable to the practicing physician, young investigator, clinical practitioners, and internists/paediatricians with strong interests in blood diseases. Seminars in Hematology publishes original research, reviews, short communications and mini- reviews.
血液学研讨会旨在介绍当前临床血液学的重要主题，包括肿瘤学、血液病理学和血库的相关领域。该杂志独特的期刊结构允许通过精选的评论文章对单个主题进行多方面的概述，同时还提供各种文章，呈现立即影响该领域的动态和前沿材料。血液学研讨会致力于使对血液疾病有强烈兴趣的执业医师、年轻研究者、临床从业人员和内科医生/儿科医生能够接触、理解和评价重要的和当前的工作。血液学研讨会发表原创研究、综述、短通讯和微型综述。
Will CAR T cell therapy have a role in AML? Promises and pitfalls.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.008
The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.002
Immune reconstitution after T-cell replete HLA-haploidentical transplantation.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.03.005
The emerging role of measurable residual disease detection in AML in morphologic remission.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.09.001
Acquired and germline predisposition to bone marrow failure: Diagnostic features and clinical implications.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.016
Maintenance therapy in acute myeloid leukemia: What is the future?
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.006
Genetic and epigenetic determinants of AML pathogenesis.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.001
Haploidentical donor transplants for severe aplastic anemia.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.03.004
Curative strategies in APL.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.07.004
Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and results.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.09.002
The current approach to the diagnosis of myelodysplastic syndromes☆.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.05.015
Mass spectrometry and proteomics in hematology.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.009
Is human leukocyte antigen-matched sibling donor transplant always better than haploidentical allograft?
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.07.005
Next generation sequencing in hematolymphoid neoplasia.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.006
Profiling of lymphoma from formalin-fixed paraffin-embedded tissue.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.003
Poor graft function after allogeneic hematopoietic stem cell transplantation-an old complication with new insights☆.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.004
Advances in diagnosis of mastocytosis and hypereosinophilic syndrome☆.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.005
Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.01.001
The challenging task of enumerating blasts in the bone marrow.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.07.001
Shifting paradigms in the treatment of older adults with AML.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.02.002
Molecular assessment of clonality in lymphoid neoplasms.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.008
Risks and benefits in a personalized application of allogeneic transplantation in patients with AML in first CR.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.009
Who is the best donor for haploidentical stem cell transplantation?
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.003
Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2019.11.004
New approaches in allogenic transplantation in AML.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2018.08.007
Genetic studies in the evaluation of myeloproliferative neoplasms.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.004
Mobilization and collection of cells in the hematologic compartment for cellular therapies: Stem cell collection with G-CSF/plerixafor, collecting lymphocytes/monocytes.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2019.11.003
Mechanisms and therapeutic prospects of thrombopoietin receptor agonists.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2019.09.001
Prophylaxis and treatment of relapse after haploidentical stem cell transplantation: What is known vs unknown?
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.04.001
Issues in the development of hemoglobin based oxygen carriers.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2019.11.006
Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates☆.
来源期刊：Seminars in hematologyDOI：10.1053/j.seminhematol.2018.05.011
Granulocyte transfusions: Current science and perspectives.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.11.002
Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.03.003
Red Cell Transfusions in the Genomics Era.
来源期刊：Seminars in hematologyDOI：10.1053/J.SEMINHEMATOL.2019.11.001
